LABIXIAOXIN (01262) announced that the Group expects to achieve an after-tax profit of approximately RMB 2 million for the six months ended June 30, 2025, compared to an after-tax loss of RMB 43.6 million in the corresponding period of 2024. The increase in after-tax profit is attributed to reduced advertising and promotional expenses and lower expected credit loss provisions for the six months ended June 30, 2025, compared to the same period in 2024.